China Law and Practice1 天
In the News: Pharma Data Protection Rules; Facial Recognition Restrictions; and UBS Fully ...
China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate ...
China Law and Practice3 天
Illumina’s Inclusion in China’s Unreliable Entity List: Patent Wars, Geopolitical Risks ...
Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications of, Illumina’s inclusion in China’s ...